Back to companies

Karuna Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Karuna Therapeutics Inc, a subsidiary of Bristol-Myers Squibb Co operates within the pharmaceuticals and healthcare industry, specifically focusing on the therapy area of central nervous system disorders, with a specialization in schizophrenia. It is involved in the research, development, and production of medications and treatments for individuals with schizophrenia. The company is headquartered in the US.

 Gain a 360-degree view of Karuna Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Karuna Therapeutics Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 26th Floor, 99 High Street, Boston, Massachusetts, 02110
Website karunatx.com
Telephone 1 857 4492244
No of Employees 339
Industry Pharmaceuticals and Healthcare
Revenue (2023) $654,000
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Karuna Therapeutics Inc premium industry data and analytics

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Karuna Therapeutics Inc’s relevant decision makers and contact details.

40+

Catalyst Calendar

Proactively evaluate Karuna Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Clinical Trials

Determine Karuna Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

9

Pipeline Drugs

Identify which of Karuna Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Karuna Therapeutics Inc key executives to enhance your sales strategy Gain insight into Karuna Therapeutics Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?